NFB-12. Effect of trametinib on leg length discrepancy in a child with NF1 related plexiform neurofibroma

INTRODUCTION: Plexiform neurofibroma(PN) is a challenging benign tumor. Recently, MEK inhibitors (MEKi) showed encouraging tumor response. We report the observed effect of Trametinib on leg length discrepancy (LLD) in a child with NF1. CASE DESCRIPTION: A 4 year old girl with sporadic NF1, developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradeep, Celia, Abouassaly, Marcel, Assis, Zarina, Finkbeiner, Melanie, Lafay-Cousin, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neurofibromatosis and other Predisposition Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164962/
http://dx.doi.org/10.1093/neuonc/noac079.474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164962/
http://dx.doi.org/10.1093/neuonc/noac079.474

Ejemplares similares